4//SEC Filing
Melnick David A. 4
Accession 0000899243-21-034503
CIK 0001701108other
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 4:15 PM ET
Size
5.1 KB
Accession
0000899243-21-034503
Insider Transaction Report
Form 4
Melnick David A.
Chief Medical Officer
Transactions
- Award
Common Stock
2021-08-26+24,067→ 24,067 total
Footnotes (1)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on August 26, 2022, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001726485
Filing Metadata
- Form type
- 4
- Filed
- Aug 29, 8:00 PM ET
- Accepted
- Aug 30, 4:15 PM ET
- Size
- 5.1 KB